SEC Form 10-K filed by Eightco Holdings Inc.

Easton, PA, April 28, 2025 (GLOBE NEWSWIRE) -- Eightco Holdings Inc. (NASDAQ:OCTO) (the "Company" or "Eightco") today announced the appointment of Nicola Caiano to its Board of Directors. Mr. Caiano brings over three decades of expertise in financial strategy, capital markets, and investment management, further strengthening Eightco's strategic vision and growth trajectory. Mr. Caiano currently serves as Chief Financial Officer at Cytometric Therapeutics, where he leads capital formation strategies to fund clinical trials for groundbreaking cancer therapies. He is also the Founding Partner of Olea Management LLC, where he advises family offices and early-stage companies across diverse ind

4 - Eightco Holdings Inc. (0001892492) (Issuer)

3 - Eightco Holdings Inc. (0001892492) (Issuer)

4 - Eightco Holdings Inc. (0001892492) (Issuer)

10-Q - Eightco Holdings Inc. (0001892492) (Filer)

8-K - Eightco Holdings Inc. (0001892492) (Filer)

10-K - Eightco Holdings Inc. (0001892492) (Filer)

SC 13G/A - Eightco Holdings Inc. (0001892492) (Subject)

SAFETY HARBOR, Florida, April 06, 2023 (GLOBE NEWSWIRE) -- Eightco Holdings Inc., a publicly-traded company listed on NASDAQ under the ticker symbol OCTO, is pleased to announce that it will be releasing its comprehensive annual financial results and operational update for the year 2022. This eagerly-anticipated release is scheduled to take place on or before Monday, April 17, 2023 and will provide a comprehensive overview of the company's financial performance and operational activities throughout the previous year. About Eightco Holdings Inc. Eightco Holdings Inc. (NASDAQ:OCTO) is committed to growth focused around its existing subsidiaries, Forever 8, an inventory management platform

Quarter Driven by Focus on Deploying Capital into the Refurbished Apple Products Business and Prioritizing Financial Stability for Long-Term Growth First quarter 2025 revenue growth of 25% to $9.9mn compared to $8.0mn for the prior year quarter, due to focus on refurbished apple products salesFirst quarter 2025 operating loss of $1.4mn, a reduction of 55% compared to an operating loss of $3.2mn for the prior year quarter, due to lower SG&A and absence of restructuring and severance expenses in the first quarter of 2025 Easton, PA, May 16, 2025 (GLOBE NEWSWIRE) -- Eightco Holdings Inc. (NASDAQ:OCTO) (the "Company" or "Eightco") today announced financial results for the three months ended

Easton, PA, April 28, 2025 (GLOBE NEWSWIRE) -- Eightco Holdings Inc. (NASDAQ:OCTO) (the "Company" or "Eightco") today announced the appointment of Nicola Caiano to its Board of Directors. Mr. Caiano brings over three decades of expertise in financial strategy, capital markets, and investment management, further strengthening Eightco's strategic vision and growth trajectory. Mr. Caiano currently serves as Chief Financial Officer at Cytometric Therapeutics, where he leads capital formation strategies to fund clinical trials for groundbreaking cancer therapies. He is also the Founding Partner of Olea Management LLC, where he advises family offices and early-stage companies across diverse ind

2024 revenues of $39.6 million down from $67.6 million, driven by reduction in capital available for cell phone sales after repayment of the previously outstanding convertible note2024 Gross Profit of $6.0 million, down from $6.2mn Easton, PA, April 15, 2025 (GLOBE NEWSWIRE) -- Eightco Holdings Inc. (NASDAQ:OCTO) (the "Company" or "Eightco"), today announced financial results for the fiscal year ended December 31, 2024. Paul Vassilakos, CEO of Eightco and President of Forever 8 Fund, LLC ("Forever 8"), the Company's largest subsidiary, said "We continue to improve all aspects of our cost structure and focus on our highest growth priorities to deliver long-term value to shareholders. In t